Volume 54, Issue 4, Pages (October 2008)

Slides:



Advertisements
Similar presentations
The PSA Era is not Over for Prostate Cancer
Advertisements

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis  Maria I. Carlo, Darren R.
Volume 58, Issue 2, Pages (August 2010)
Volume 58, Issue 4, Pages (October 2010)
Volume 58, Issue 1, Pages (July 2010)
Volume 66, Issue 6, Pages (December 2014)
Single-Incision, Umbilical Laparoscopic versus Conventional Laparoscopic Nephrectomy: A Comparison of Perioperative Outcomes and Short-Term Measures of.
Volume 61, Issue 6, Pages (June 2012)
Volume 49, Issue 2, Pages (February 2006)
Bilateral Renal Mass Suggestive of Cancer
Volume 52, Issue 1, Pages (July 2007)
Lymph Node Dissection in Renal Cell Carcinoma
Volume 53, Issue 5, Pages (May 2008)
Volume 74, Issue 2, Pages (August 2018)
The Role of Residual Tumor Resection in Patients with Metastatic Renal Cell Carcinoma and Partial Remission following Immunochemotherapy  Olaf A. Brinkmann,
Let the Games Begin (with EAU Approval)
Volume 68, Issue 1, Pages (July 2015)
Volume 72, Issue 5, Pages (November 2017)
Volume 71, Issue 4, Pages (April 2017)
Volume 50, Issue 5, Pages (November 2006)
Volume 66, Issue 3, Pages (September 2014)
Volume 59, Issue 2, Pages (February 2011)
Daily Administration of Phosphodiesterase Type 5 Inhibitors for Urological and Nonurological Indications  Anthony J. Bella, Ling X. DeYoung, Mussa al-Numi,
Volume 53, Issue 2, Pages (February 2008)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 54, Issue 4, Pages (October 2008)
Volume 61, Issue 5, Pages (May 2012)
Volume 52, Issue 5, Pages (November 2007)
Volume 68, Issue 1, Pages 5-7 (July 2015)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Volume 68, Issue 3, Pages (September 2015)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 67, Issue 6, Pages (June 2015)
Volume 60, Issue 4, Pages (October 2011)
Volume 60, Issue 5, Pages (November 2011)
Volume 57, Issue 4, Pages e41-e42 (April 2010)
International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia  Brett Delahunt, John R. Srigley, Lars Egevad,
Volume 64, Issue 6, Pages (December 2013)
The PSA Era is not Over for Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Volume 65, Issue 2, Pages (February 2014)
Volume 64, Issue 4, Pages (October 2013)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Volume 66, Issue 6, Pages (December 2014)
Volume 66, Issue 6, Pages (December 2014)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 59, Issue 1, Pages (January 2011)
Use of the National Health and Nutrition Examination Survey to Calculate the Impact of Obesity and Diabetes on Cost and Prevalence of Urolithiasis in.
The Economic Costs of Overactive Bladder in Germany
Is Simple Enucleation a Minimal Partial Nephrectomy Responding to the EAU Guidelines’ Recommendations?  Vincenzo Ficarra, Antonio Galfano, Stefano Cavalleri 
Volume 50, Issue 5, Pages (November 2006)
Volume 50, Issue 2, Pages (August 2006)
Volume 71, Issue 5, Pages (May 2017)
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Prognostic Impact of Comorbidity in Patients with Bladder Cancer
Sergio Bracarda  European Urology Supplements 
Volume 64, Issue 1, Pages (July 2003)
European Urology is “Your” Journal
Epidemiology of Renal Cell Carcinoma
Volume 53, Issue 6, Pages (June 2008)
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Supportive care for patients with renal disease: Time for action
Impact of antibiotic restrictions: the patient's perspective
Jan Roigas  European Urology Supplements 
Volume 54, Issue 1, Pages (July 2008)
Limited operation for severe multisegmental bilateral bronchiectasis
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 54, Issue 4, Pages 855-865 (October 2008) The Impact of Temporal Presentation on Clinical and Pathological Outcomes for Patients with Sporadic Bilateral Renal Masses  Stephen A. Boorjian, Paul L. Crispen, Christine M. Lohse, Bradley C. Leibovich, Michael L. Blute  European Urology  Volume 54, Issue 4, Pages 855-865 (October 2008) DOI: 10.1016/j.eururo.2008.04.079 Copyright © 2008 Terms and Conditions

Fig. 1 Analysis of 310 patients with bilateral solid renal tumors. European Urology 2008 54, 855-865DOI: (10.1016/j.eururo.2008.04.079) Copyright © 2008 Terms and Conditions

Fig. 2 Estimated CSS (left) and OS (right) ± standard error, number still at risk for 92 patients with synchronous bilateral RCC versus 81 patients with metachronous bilateral RCC. European Urology 2008 54, 855-865DOI: (10.1016/j.eururo.2008.04.079) Copyright © 2008 Terms and Conditions

Fig. 3 Estimated CSS (left) and OS (right) in patients with synchronous bilateral RCC versus patients with unilateral RCC and a simultaneous solitary metastasis treated with nephrectomy and metastectomy. European Urology 2008 54, 855-865DOI: (10.1016/j.eururo.2008.04.079) Copyright © 2008 Terms and Conditions

Fig. 4 Estimated CSS (left) and OS (right) in patients with metachronous bilateral RCC versus patients who underwent complete resection of a solitary metachronous metastasis at other, distant sites following nephrectomy for pTanyNanyM0 disease. European Urology 2008 54, 855-865DOI: (10.1016/j.eururo.2008.04.079) Copyright © 2008 Terms and Conditions